Galmed Pharmaceuticals Ownership | Who Owns Galmed Pharmaceuticals?


OverviewForecastFinancialsChart

Galmed Pharmaceuticals Ownership Summary


Galmed Pharmaceuticals is owned by 122.72% institutional investors. Delaware Healthcare I is the top mutual fund, with 0.11% of its assets in Galmed Pharmaceuticals shares.

GLMD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGalmed Pharmaceuticals122.72%--22.72%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2023215.00%2,061,931-14.64%1220.59%740.00%4-63.64%
Dec 31, 202220-13.04%2,415,592-6.53%1430.61%5-37.50%1157.14%
Sep 30, 2022234.55%2,584,2872.46%1530.68%8-20.00%7133.33%
Jun 30, 202222-12.00%2,522,184-10.31%1500.54%1066.67%3-40.00%
Mar 31, 202225-3.85%2,812,117-27.44%1670.31%6-25.00%5-16.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Delaware Healthcare I1.70K0.11%-
Fidelity Nasdaq Composite Index152.000.01%1.00
Blackstone Alternative Multi-Strategy I407.000.00%-93.00

GLMD Ownership FAQ


Who Owns Galmed Pharmaceuticals?

Galmed Pharmaceuticals shareholders are primarily institutional investors at 122.72%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Galmed Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Galmed Pharmaceuticals exceeds.

Does Blackrock own Galmed Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Galmed Pharmaceuticals.

Who is the top mutual fund holder of Galmed Pharmaceuticals shares?

Delaware Healthcare I is the top mutual fund holder of Galmed Pharmaceuticals shares, with 0.11% of its total shares outstanding invested in 1.7K Galmed Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools